FDA.reportPublic FDA data

LISINOPRIL

Product NDC
31722-422
11-digit product format
317220422
Labeler code
31722
Product ID
31722-422_059f5795-5de9-4a69-bced-580cf6272799
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LISINOPRIL
Dosage form
TABLET
Route
ORAL
Labeler
Camber Pharmaceuticals Inc.
Application
ANDA203508
Marketing category
ANDA
Marketing start
2013-11-15
Marketing end
0000-00-00
Substance
LISINOPRIL
Active strength
40 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
31722-422-012025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-052025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-102025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-302025-02-20C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-012020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-052020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-102020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7
31722-422-302020-01-31C16284748780-19d75b9d0-c901-f424-e053-dadaa90a57ce855911f3-ce9e-4cdf-ad7e-a1a5109f5ad7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
31722-422-01EA - Each31722-4224ecb2005-a5dc-4df7-92c3-38fdf20e071a12014-02-04
31722-422-10EA - Each31722-4229467610b-26c7-4991-b0fa-4d3ffff6625512014-02-04